Department of Rehabilitation Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Pediatrics, Akitsu Ryoiku-en, Tokyo, Japan.
Brain Dev. 2024 Sep;46(8):268-273. doi: 10.1016/j.braindev.2024.06.001. Epub 2024 Jun 13.
To investigate whether patients with severe motor and intellectual disability (SMID) have nutritional vitamin D and K insufficiencies and clarify the required vitamin supplementation.
This prospective observational study enrolled Japanese adults with SMID receiving institutionalized care who underwent blood sampling between February 2020 and February 2022 during annual medical checkups. Serum vitamin K and 25-hydroxy vitamin D (25(OH)D) levels were measured to determine their relationship with serum uncarboxylated osteocalcin (ucOC) levels. Vitamin D and K intake was compared among tube-fed and oral-intake patients with SMID and control participants using corresponding serum levels.
The study included 124 patients with SMID (56 men and 68 women; mean age: 53.0 years) and 20 control participants. Serum 25(OH)D levels were significantly higher in the SMID group than in the control group and the oral intake SMID group than in the tube-fed SMID group. In the tube-fed SMID group, vitamin D intake was lower than the daily recommended intake and correlated with serum 25(OH)D levels. Daily vitamin K intake in the tube-fed group was lower than recommended but not correlated with serum vitamin K levels. Serum ucOC levels were significantly higher in the SMID group than in the control group. Tube feeding was significantly and positively correlated with serum 25(OH)D levels. Serum 25(OH)D levels were not correlated with serum vitamin K levels.
The SMID group had higher ucOC levels than the control group, possibly owing to daily vitamin K and D deficiencies. Vitamin D supplementation is recommended to decrease ucOC levels.
研究严重运动和智力障碍(SMID)患者是否存在营养性维生素 D 和 K 不足,并阐明所需的维生素补充。
本前瞻性观察研究纳入了 2020 年 2 月至 2022 年 2 月期间在年度体检期间接受机构护理的日本 SMID 成年患者,对其进行了血液采样。测量血清维生素 K 和 25-羟维生素 D(25(OH)D)水平,以确定其与未羧化骨钙素(ucOC)水平的关系。使用相应的血清水平比较了 SMID 管饲和口服患者与对照组之间的维生素 D 和 K 摄入量。
该研究纳入了 124 名 SMID 患者(56 名男性和 68 名女性;平均年龄:53.0 岁)和 20 名对照组参与者。SMID 组的血清 25(OH)D 水平明显高于对照组和口服 SMID 组高于管饲 SMID 组。在管饲 SMID 组中,维生素 D 摄入量低于每日推荐摄入量,并与血清 25(OH)D 水平相关。管饲组的每日维生素 K 摄入量低于推荐量,但与血清维生素 K 水平无关。SMID 组的血清 ucOC 水平明显高于对照组。管饲与血清 25(OH)D 水平呈显著正相关。血清 25(OH)D 水平与血清维生素 K 水平无关。
SMID 组的 ucOC 水平高于对照组,可能是由于每日维生素 K 和 D 缺乏。建议补充维生素 D 以降低 ucOC 水平。